呼吸

慢性阻塞性肺疾病的物理活动咨询方案的短期和长期影响:一项随机对照试验

作者:高翠歌 编译 来源:金宝搏网站登录技巧 日期:2016-05-17
导读

         慢性阻塞性肺疾病的物理活动咨询方案的短期和长期影响:一项随机对照试验

Short- and long-term effects of a physical activity counselling programme in COPD: A randomized controlled trial

Wytske A. Altenburge, Nick H.T. ten Hacken, Linda Bossenbroek, Huib A.M. Kerstjens, Mathieu H.G. de Greef, Johan B. Wempe

Background

 

We were interested in the effects of a physical activity (PA) counselling programme in three groups of COPD patients from general practice (primary care), outpatient clinic (secondary care) and pulmonary rehabilitation (PR).

Methods

 

In this randomized controlled trial 155 COPD patients, 102 males, median (IQR) age 62 (54–69) y, FEV1predicted 60 (40–75) % were assigned to a 12-weeks' physical activity counselling programme or usual care. Physical activity (pedometer (Yamax SW200) and metabolic equivalents), exercise capacity (6-min walking distance) and quality of life (Chronic Respiratory Questionnaire and Clinical COPD Questionnaire) were assessed at baseline, after three and 15 months.

Results

 

A significant difference between the counselling and usual care group in daily steps (803 steps, p = 0.001) and daily physical activity (2214 steps + equivalents, p = 0.001)) from 0 to 3 months was found in the total group, as well as in the outpatient (1816 steps, 2616 steps + equivalents, both p = 0.007) and PR (758 steps, 2151 steps + equivalents, both p = 0.03) subgroups. From 0 to 15 months no differences were found in physical activity. However, when patients with baseline physical activity>10,000 steps per day (n = 8), who are already sufficiently active, were excluded, a significant long-term effect of the counselling programme on daily physical activity existed in the total group (p = 0.02). Differences in exercise capacity and quality of life were found only from 0 to 3 months, in the outpatient subgroup.

Conclusion

 

Our PA counselling programme effectively enhances PA level in COPD patients after three months. Sedentary patients at baseline still benefit after 15 months.

 

ClinicalTrials.gov: registration number NCT00614796.

respiratory medicine

January 2015Volume 109, Issue 1, Pages 112–121

DOI: http://dx.doi.org/10.1016/j.rmed.2014.10.020 |

分享:

相关文章

评论

我要跟帖
发表
回复 小鸭梨
发表

copyright©金宝搏网站登录技巧 版权所有,未经许可不得复制、转载或镜像

京ICP证120392号  京公网安备110105007198  京ICP备10215607号-1  (京)网药械信息备字(2022)第00160号
//站内统计 //百度统计 //谷歌统计 //站长统计
*我要反馈: 姓    名: 邮    箱:
Baidu
map